These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 574019)

  • 1. A radioimmunoassay for cytosine arabinoside.
    Piall EM; Aherne GW; Marks VM
    Br J Cancer; 1979 Oct; 40(4):548-56. PubMed ID: 574019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitive radioimmunoassay for cytarabine and uracil arabinoside in plasma.
    Sato T; Morozumi M; Kodama K; Kuninaka A; Yoshino H
    Cancer Treat Rep; 1984 Nov; 68(11):1357-66. PubMed ID: 6498853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A radioimmunoassay for 1-beta-D-arabinofuranosyluracil with reference to cross-reactivity of 1-beta-D-arabinofuranosylcytosine with an antibody.
    Okabayashi T; Mihara S; Repke DB; Moffatt JG
    Cancer Res; 1977 Sep; 37(9):3132-5. PubMed ID: 18280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A radioimmunoassay method for 1-beta-D-arabinofuranosyluracil using antibodies directed against 1-beta-D-arabinofuranosylcytosine.
    Okabayashi T; Mihara S; Moffatt JG
    Cancer Res; 1977 Feb; 37(2):625-8. PubMed ID: 12864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in the intracellular pharmacokinetics of cytosine arabinoside (AraC) between circulating leukemic blasts and normal mononuclear blood cells.
    Hiddemann W; Schleyer E; Unterhalt M; Zühlsdorf M; Rolf C; Reuter C; Kewer U; Uhrmeister C; Wörmann B; Büchner T
    Leukemia; 1992 Dec; 6(12):1273-80. PubMed ID: 1453772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing therapy for acute myeloid leukemia based on differences in intracellular metabolism of cytosine arabinoside between leukemic blasts and normal mononuclear blood cells.
    Hiddemann W; Schleyer E; Unterhalt M; Kern W; Büchner T
    Ther Drug Monit; 1996 Aug; 18(4):341-9. PubMed ID: 8857548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ion-pair liquid chromatography of cytarabine and uracil-arabinoside in human plasma.
    Burk M; Volmer M; Fartash K; Schneider W
    Arzneimittelforschung; 1995 May; 45(5):616-9. PubMed ID: 7612064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AraU accumulation in patients with renal insufficiency as a potential mechanism for cytarabine neurotoxicity.
    Lindner LH; Ostermann H; Hiddemann W; Kiani A; Würfel M; Illmer T; Karsch C; Platzbecker U; Ehninger G; Schleyer E
    Int J Hematol; 2008 Nov; 88(4):381-386. PubMed ID: 18836794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromatographic analysis (TLC) of uracil arabinoside, cytosine arabinoside, uracil and cytosine in human plasma.
    Paw B; Misztal G
    Acta Pol Pharm; 1995; 52(6):455-7. PubMed ID: 8960263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPLC-MS/MS method for the simultaneous determination of MB07133 and its metabolites, cytarabine and arabinofuranosyluracil, in rat plasma.
    Wang D; Xiao Q; Yang W; Qian W; Yang J
    J Pharm Biomed Anal; 2016 Feb; 120():228-34. PubMed ID: 26760240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytosine arabinoside transport and metabolism in acute leukemias and T cell lymphoblastic lymphoma.
    Wiley JS; Taupin J; Jamieson GP; Snook M; Sawyer WH; Finch LR
    J Clin Invest; 1985 Feb; 75(2):632-42. PubMed ID: 3871794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of high-dose cytarabine and its deamination product--a reappraisal.
    Burk M; Heyll A; Arning M; Volmer M; Fartash K; Schneider W
    Leuk Lymphoma; 1997 Oct; 27(3-4):321-7. PubMed ID: 9402329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A radioimmunoassay for the new antiviral agent 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil.
    Jagoda E; Ogan M; Stouffer B; Tsay HM; Turabi N; Mantha S; Yost F; Tu JI
    Ther Drug Monit; 1992 Dec; 14(6):499-508. PubMed ID: 1485373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A sensitive and specific radioimmunoassay for 1-beta-D-arabino-furanosylcytosine.
    Shimada N; Ueda T; Yokoshima T; Oh-Ishi J; Oh-oka T
    Cancer Lett; 1984 Sep; 24(2):173-8. PubMed ID: 6478445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A radioimmunoassay for 1-beta-D-arabinofuranosylcytosine.
    Okabayashi T; Mihara S; Repke DB; Moffatt JG
    Cancer Res; 1977 Feb; 37(2):619-24. PubMed ID: 832282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-performance liquid chromatographic analysis of cytosine arabinoside and metabolites in biological samples.
    Pallavicini MG; Mazrimas JA
    J Chromatogr; 1980 Oct; 183(4):449-58. PubMed ID: 7430297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extraction and analytic procedures for cytosine arabinoside and 1-beta-D-arabinofuranosyluracil and their 5'-mono-, di-, and tri-phosphates.
    Kreis W; Gordon C; Gizoni C; Woodcock T
    Cancer Treat Rep; 1977 Jul; 61(4):643-6. PubMed ID: 195728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of intracellular metabolism of cytosine arabinoside in acute myeloid leukemia by granulocyte-macrophage colony-stimulating factor.
    Reuter C; Auf der Landwehr U; Schleyer E; Zühlsdorf M; Ameling C; Rolf C; Wörmann B; Büchner T; Hiddemann W
    Leukemia; 1994 Feb; 8(2):217-25. PubMed ID: 8309245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liquid-chromatographic monitoring of cytosine arabinoside and its metabolite, uracil arabinoside, in serum.
    Wermeling JR; Pruemer JM; Hassan FM; Warner A; Pesce AJ
    Clin Chem; 1989 Jun; 35(6):1011-5. PubMed ID: 2731341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukaemic blasts differ from normal bone marrow mononuclear cells and CD34+ haemopoietic stem cells in their metabolism of cytosine arabinoside.
    Braess J; Wegendt C; Feuring-Buske M; Riggert J; Kern W; Hiddemann W; Schleyer E
    Br J Haematol; 1999 May; 105(2):388-93. PubMed ID: 10233409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.